PUNEET SUD: Open Payments
NPI 1598762346 · CRANSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 37 payments from 13 companies in 2025. Trend: 2023 $1,284 · 2024 $857 · 2025 $859
Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $194 |
| PFIZER INC. | 5 | $168 |
| Lilly USA, LLC | 5 | $131 |
| ABBVIE INC. | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
| Braeburn Inc. | 1 | $19 |
Products named: PREVNAR 20, Rybelsus, VRAYLAR, JARDIANCE, Ozempic, MOUNJARO, ZORYVE, AIRSUPRA.
Industry payments across RI — which companies pay providers there.
